Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 196
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Dicty World Race - finding the fastest and smartest Dicty cells

    On May 16, Dicty and HL60 cells will race for the "fastest &smartest" title. Both cell types are models...

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better...

    Are Implanted Prosthetic Legs for Horses Possible?

    An unacceptable number of otherwise healthy horses are euthanized each year from lower limb ailments for...

    Backer Badge Funded